Literature DB >> 30014497

Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms.

Muxuan Liang1, Ting Ye1, Haoda Fu2.   

Abstract

With the advancement in drug development, multiple treatments are available for a single disease. Patients can often benefit from taking multiple treatments simultaneously. For example, patients in Clinical Practice Research Datalink with chronic diseases such as type 2 diabetes can receive multiple treatments simultaneously. Therefore, it is important to estimate what combination therapy from which patients can benefit the most. However, to recommend the best treatment combination is not a single label but a multilabel classification problem. In this paper, we propose a novel outcome weighted deep learning algorithm to estimate individualized optimal combination therapy. The Fisher consistency of the proposed loss function under certain conditions is also provided. In addition, we extend our method to a family of loss functions, which allows adaptive changes based on treatment interactions. We demonstrate the performance of our methods through simulations and real data analysis.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  deep learning; individualized treatment recommendation; multilabel classification; outcome weighted learning; precision medicine

Mesh:

Year:  2018        PMID: 30014497     DOI: 10.1002/sim.7902

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Estimating individualized treatment regimes from crossover designs.

Authors:  Crystal T Nguyen; Daniel J Luckett; Anna R Kahkoska; Grace E Shearrer; Donna Spruijt-Metz; Jaimie N Davis; Michael R Kosorok
Journal:  Biometrics       Date:  2019-12-19       Impact factor: 2.571

2.  Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making.

Authors:  Alan Brnabic; Lisa M Hess
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-15       Impact factor: 2.796

3.  Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning.

Authors:  Tianyu Zhan; Alan Hartford; Jian Kang; Walter Offen
Journal:  Stat Biopharm Res       Date:  2020-08-24       Impact factor: 1.586

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.